<bill session="107" type="hr" number="11" updated="2013-07-14T18:56:43-04:00">
  <state datetime="2001-01-03">REFERRED</state>
  <status>
    <introduced datetime="2001-01-03"/>
  </status>
  <introduced datetime="2001-01-03"/>
  <titles>
    <title as="introduced" type="official">Expressing the sense of the House of Representatives that oversight hearings should be held immediately to determine the causes and outcomes surrounding this influenza season's vaccine shortage.</title>
  </titles>
  <sponsor id="400505"/>
  <cosponsors>
    <cosponsor id="400050" joined="2001-01-31"/>
    <cosponsor id="400100" joined="2001-01-31"/>
    <cosponsor id="400152" joined="2001-01-31"/>
    <cosponsor id="400347" joined="2001-01-31"/>
    <cosponsor id="400413" joined="2001-01-31"/>
  </cosponsors>
  <actions>
    <action state="REFERRED" datetime="2001-01-03">
      <text>Referred to the House Committee on Energy and Commerce.</text>
      <reference ref=" CR H20" label="text of measure as introduced"/>
    </action>
    <action datetime="2001-02-07">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Committee on Energy and Commerce"/>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Business ethics"/>
    <term name="Commerce"/>
    <term name="Congress"/>
    <term name="Congressional hearings"/>
    <term name="Congressional investigations"/>
    <term name="Congressional oversight"/>
    <term name="Drug industry"/>
    <term name="Influenza"/>
    <term name="Medical ethics"/>
    <term name="Profit"/>
    <term name="Vaccines"/>
  </subjects>
  <amendments/>
  <summary>1/3/2001--Introduced.
Expresses the sense of the House of Representatives that oversight hearings should be convened immediately to determine: (1) the course of action followed by distributors of influenza vaccine during this influenza season; (2) whether or not such distributors put profit ahead of the health and well-being of the American people; and (3) whether it is necessary to take measures to ensure the safe, adequate, and timely supply of influenza vaccines in the future.</summary>
</bill>
